354 related articles for article (PubMed ID: 10485547)
1. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
Salomão DR; Mathers WD; Sutphin JE; Cuevas K; Folberg R
Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
[TBL] [Abstract][Full Text] [Related]
2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
Schmidt M; Maier M; Schmidt T; Klaehsen D; Merté RL
Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
[TBL] [Abstract][Full Text] [Related]
4. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Werschnik C; Lommatzsch PK
Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
[TBL] [Abstract][Full Text] [Related]
5. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
Pe'er J; Frucht-Pery J
Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
[TBL] [Abstract][Full Text] [Related]
6. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
[TBL] [Abstract][Full Text] [Related]
7. [Conjunctival primary acquired melanosis].
Krohn J; Monge OR
Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
[TBL] [Abstract][Full Text] [Related]
8. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
Sugiura M; Colby KA; Mihm MC; Zembowicz A
Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
10. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
Akpek EK; Ertoy D; Kalayci D; Hasiripi H
Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
[TBL] [Abstract][Full Text] [Related]
11. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
Finger PT; Czechonska G; Liarikos S
Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
[TBL] [Abstract][Full Text] [Related]
12. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Kurli M; Finger PT
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
Ditta LC; Shildkrot Y; Wilson MW
Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
[TBL] [Abstract][Full Text] [Related]
14. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
Frucht-Pery J; Pe'er J
Arch Ophthalmol; 1996 Oct; 114(10):1261-4. PubMed ID: 8859090
[TBL] [Abstract][Full Text] [Related]
15. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
Chalasani R; Giblin M; Conway RM
Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772
[TBL] [Abstract][Full Text] [Related]
16. Primary acquired melanosis of the conjunctiva.
Lin SM; Ferrucci S
Optometry; 2006 May; 77(5):223-8. PubMed ID: 16651212
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ocular surface squamous neoplasia with Mitomycin C.
Gupta A; Muecke J
Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
[TBL] [Abstract][Full Text] [Related]
18. Topical mitomycin C in the treatment of pigmented conjunctival lesions.
Rodríguez-Ares T; Touriño R; De Rojas V; Becerra E; Capeans C
Cornea; 2003 Mar; 22(2):114-7. PubMed ID: 12605043
[TBL] [Abstract][Full Text] [Related]
19. Finding of conjunctival melanocytic pigmented lesions within pterygium.
Perra MT; Colombari R; Maxia C; Zucca I; Piras F; Corbu A; Bravo S; Scarpa A; Sirigu P
Histopathology; 2006 Mar; 48(4):387-93. PubMed ID: 16487360
[TBL] [Abstract][Full Text] [Related]
20. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Tunc M; Erbilen E
Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
